Kansas City Mission Committee volunteer April Schoenberg spoke with Community Engagement Senior Specialist Paula Mukherjee ...

PanCAN Chief Scientific and Medical Officer Anna Berkenblit discusses how PanCAN supports all patients diagnosed with ...

We're the national organization providing support, resources, volunteer opportunities and hope for people fighting pancreatic ...

With No Standard Early Detection Test for the General Public, Leading Nonprofit Dedicated to Advancing Progress Encourages ...

PanCAN welcomes Jon Mahrt, Chief Executive Officer of Optum Rx and Chief Growth Officer of Optum to the Board of Directors. In this Q&A, Jon shares his personal connection to the cause, his passion ...

Editor’s note: In this heartfelt interview, Jaylen Baron shares the story of her mother, Jane – an inspiring dance teacher, mentor and fighter – whose legacy is honored every year at PanCAN ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...

Looking for a fresh, nutrient-packed meal? This Bright & Fresh Citrus Strawberry Salad is packed with vitamins, antioxidants, and lean protein—supporting overall health and helping to reduce the risk ...

For many people, food is meaningful in ways that go beyond carbohydrates, protein and calories. Meals bring us together with loved ones, remind us of cherished memories and connect us to our cultural ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...

The U.S. Food and Drug Administration has granted accelerated approval for a new drug targeting a tumor alteration called NRG1 gene fusion found in roughly 3% of patients with pancreatic ...

A device already approved to treat several other types of cancer has shown positive results for a subset of patients with pancreatic cancer. In a Phase III clinical trial, a therapy known as Tumor ...